Elite Diagnostic Limited (JMSE:ELITE)

Market Cap	452.35M -43.9%
Revenue (ttm)	875.78M +0.3%
Net Income	48.88M +33.1%
EPS	0.14 +33.1%
Shares Out	353.40M
PE Ratio	9.26
Forward PE	n/a
Dividend	0.01 (0.78%)
Ex-Dividend Date	n/a

Volume	25,662
Open	n/a
Previous Close	1.280
Day's Range	1.280 - 1.330
52-Week Range	1.020 - 2.000
Beta	0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Elite Diagnostic

Elite Diagnostic Limited provides diagnostic imaging services in Jamaica. The company medical imaging services, including CT scan, MRI, x-ray, ultrasound, and fluoroscopy services. It also provides interventional procedures, including angiograms, catheter insertion, aspiration and biopsy, selective hysterosalpingogram and recanalization, lumbar puncture, sclerotherapy, and implant placement services. Elite Diagnostic Limited was incorporated in 2012 and is based in Kingston, Jamaica.

• Industry: Medical Laboratories
• Founded: 2012
• Country: Jamaica
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: ELITE

Financial Performance

In fiscal year 2025, Elite Diagnostic's revenue was 853.82 million, an increase of 3.96% compared to the previous year's 821.28 million. Earnings were 32.02 million, an increase of 22.44%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 6, 2026

Data Sources Report a data error